Immunology & Immune System

Exercise-Neuro-Immunology – From Bench to Bedside

Sport-Neuro-Immunologie – von der Grundlagenforschung in die Praxis


Increased levels of physical activity are associated with a risk reduction for several neurodegenerative disorders (e.g. Multiple Sclerosis, Parkinson’s disease). Moreover, physical exercise is known to improve the physical capacity and to reduce commonlyobserved symptoms, such as motoric, cognitive and a ective impairments. In addition to the ameliorating e ects on speci c symptoms,  rst evidence also suggests that physical exercise interventions may counteract and/or alleviate the progress of these diseases.

Considering the side effects of drug therapy, exercise interventions represent a promising non-pharmacological supportive treatment option and are therefore increasinglybeinginvestigated in clinical research on neurological diseases.More knowledge about the underlying biological mechanisms is warranted in order to improve tailored exercise programs.

However, the reduced accessibility of the central nervous system in humans and problems in the transferability of rodent models complicates research in this  eld. Nevertheless, several peripheral markers indicating distinct biological pathways involved in the pathogenesis and progression of neurodegeneration have been revealed to date. Interestingly, these biomarkers have recently been described to be sensitive to exercise stimuli.

In this review, we provide an overview of the interaction between potential mechanisms linked to physical exercise and the alleviation of neurodegenerative processes. More precisely, we focus on di erent aspects of exercise-induced impacts on neuronal growth factors, in ammation, blood-brain barrier permeability and the kynurenine pathway.

KEY WORDS: Exercise, Physical Activity, Brain, Neurodegeneration, Neurological Disorders


Erhöhte Level körperlicher Aktivität sind mit einer Risikoreduktion für zahlreiche neurodegenerative Erkrankungen assoziiert (z. B. Multiple Sklerose, Parkinson-Krankheit). Darüber hinaus ist bekannt, dass Bewegungs- und Sportprogramme die physische Kapazität von Betro enen verbessern und häu gen Symptomen, wie motorischen, kognitiven und a ektiven Einschränkungen, entgegenwirken. Zusätzlich zu einer symptomlindernden Wirkung, weist erste Evidenz auch darauf hin, dass Bewegungsinterventionen einem Fortschreiten dieser Erkrankungen entgegenwirken können.

In Anbetracht der Nebenwirkungen medikamentöser  erapien stellen Trainingsinterventionen eine vielversprechende, nicht-pharmakologische supportive Behandlungsstrategie dar, welche bei klinischer Erforschung von neurologischen Erkrankungen immer häu ger untersucht wird. Um gezielte Bewegungsempfehlungen zu optimieren, muss mehr Wissen über die zugrundeliegenden biologischen Mechanismen generiert werden.

Die schlechte Zugänglichkeitdes humanen zentralen Nervensystems und die eingeschränkte Übertragbarkeit aus Tiermodellen stellt die Forschung hier vor eine besondere Herausforderung. Nichtsdestotrotz wurde aktuell eine Reihe peripherer Marker von unterschiedlichen molekularen Signalketten aufgedeckt, welche ihrerseits in die Pathogenese und die Progression von Neurodegeneration involviert sind. Interessanterweise sind diese Marker sensibel für körperliche Belastungsstimuli.

In diesem Übersichtsartikel liefern wir einen Überblick zum Zusammenspiel von potentiellen Mechanismen im Kontext von Bewegung/Sport und der Linderung neurodegenerativer Prozesse. Im Detail fokussieren wir uns auf die unterschiedlichen Aspekte belastungsinduzierter Ein üsse auf neuronale Wachstumsfaktoren, In ammation, Blut-Hirn-Schranken Permeabilität und den Kynureninpfad.

SCHLÜSSELWÖRTER: Sport, körperliche Aktivität, Gehirn, Neurodegeneration, neurologische Erkrankung


Results from epidemiological studies indicate that increased levels of physical activity are associated with a decreased risk for several neurodegenerative and neurological disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) (7, 19). First evidence also suggests, that both general physical activity and targeted exercise programs counteract a progress of neurodegenerative and neurological disorders (28, 38). Besides its positive eff ects on physical function (endurance, strength and balance), exercise programs have proven to reduce cognitive and aff ective impairments in clinical and non-clinical populations (8, 58). In order to defi ne general (e. g. for prevention) and specifi c exercise recommendations (i.e. to reduce specifi c symptoms) more precisely, detailed knowledge about the underlying mechanisms is warranted.

To date, these mechanisms are largely unknown due to several reasons. The human central nervous system (CNS) allows only restricted access in clinical trials. Although neurophysiological and imaging techniques can give hints on biological processes, they are not able to elucidate the molecular and cellular mechanisms within the CNS. In contrast, preclinical (mostly rodent) models overcome these methodological limitations and additionally provide a higher standardization (more homogenous samples, better control of confounding factors, etc.). However, it is suggested that less than 10% of results from rodent studies can be transferred to humans (33). In fact, the CNS and especially the prefrontal cortex, which is involved in cognitive and emotional processes, differs strongly between species. To provide some numbers, the prefrontal cortex accounts for less than 3,5% of the telencephalon in rodents, whereas it covers around 29% in humans (62). Therefore, only few, evolutionary highly conserved brain structures are comparable. The best investigated anatomical structure in this context is the hippocampus. As part of the temporal lobe of the telencephalon it is involved in varying cognitive processes among which memory consolidation represents the most prominent one. In regard to neurodegenerative disorders, it is worth mentioning that rodents usually do not develop these diseases due to their limited life span. Experimental inductions of these diseases may cause similar impairments as in humans, nevertheless, the underlying mechanism may differ.

Within this work, we provide an overview of biological mechanisms that are suspected to be influenced by physical activity and exercise and that are further associated with the development and progress of neurodegenerative/neurological disorders (Figure 1). Of note, these neuroprotective mechanisms are rather of general nature and do not account for only one type of disease or symptom.

Exercise and Growth Factors

The most investigated and sensible neuronal growth factors in response to exercise are the Brain-derived neurotrophic factor (BDNF), the Vascular endothelial growth factor (VEGF) and the Insulin-like growth factor (IGF)-1. In fact, chronic exercise training can lead to preserved brain volume in humans (13), potentially being a result from increases in neuronal growth factors.

Overall, most evidence exists on exercise impacting BDNF. Besides stimulating neuro-, synapto- and gliogenesis, BDNF is largely involved in processes of neuroprotection (43). In view of brain regions, BDNF is closely linked to the hippocampus, which represents a frequently affected area in different neurodegenerative diseases. Interestingly, evidence suggests a dose-response interaction between acute bouts of exercise and peripheral BDNF concentrations. Especially acute aerobic exercise lasting for at least 30 minutes provokes an intensity-dependent increase in peripheral BDNF concentrations, whereby higher intensities – e.g. 10% above ventilatory threshold (VT) compared to 20% below the VT (12) – are associated with higher BDNF levels in healthy populations. In contrast, low to moderate intensities seem to be sufficient for distinct elevations of BDNF concentration in patients with neurological (54% of maximal heart rate (48) or psychiatric (e.g. 70% of maximal oxygen uptake (57)) disorders (71). In view of chronic exercise interventions, minor increases in resting peripheral BDNF concentrations were reported (59). However, evidence suggests elevations of resting BDNF concentrations provoked by aerobic but not resistance exercise (11). Beside classical exercise protocols of continuous intensities over the whole exercise period, high intensity interval training seems to represent a superior stimulus to increase BDNF concentrations in respect to both, acute and chronic interventions (26). The potential sources of exercise-induced BDNF release is still insufficiently understood. Nevertheless, the brain itself is suggested to be responsible for a majority of peripheral BDNF elevations (46). In this context, the myokine irisin could be a key regulator of BDNF expression in response to acute exercise stimuli (14). Concerning chronic exercise, the link between irisin and BDNF appears to be questionable since BDNF concentrations have been described to increase whereas irisin levels decrease following longer-term exercise interventions (45).

VEGF is mainly responsible for angiogenesis and contributes to enhanced blood flow by restoring injured tissue. Additionally, it provokes neurogenesis and synaptic plasticity (50). Its expression is stimulated by physiologically occurring hypoxic and hypoglycaemic conditions, as they appear during acute exercise. More precisely, an elevated concentration of lactate during acute exercise leads to a stabilisation of the hypoxia-induced transcription factor 1-alpha (HIF1-α), which is followed by an activation of VEGF expression (23). Of note, animal studies reveal comparable concentrations in periphery and CNS with increased levels of VEGF after high-intensity interval exercise (39, 60).

IGF-1 is primarily expressed by the liver but can be produced by several other cell types. A variety of important functions in the development and recovery of CNS are promoted by IGF-1, such as neuroprotection and the inhibition of astrocytic response to inflammation (30). Acute aerobic and resistance exercise lead to temporary increased peripheral IGF-1 concentrations. Elevated levels were mainly observed following acute high-intensity aerobic exercise (63) and acute moderate to high-intensity resistance exercise (64). Furthermore, also chronic training interventions increase peripheral serum concentrations of IGF-1. However, no distinct dose-response relationship was revealed up to date (25). Evidence from animal studies has already shown both, an increase of IGF-1 in peripheral blood and hippocampus (6).

In conclusion, acute bouts of exercise indicate similar responses of BDNF, VEGF and IGF-1. More detailed, a dose-response relationship is suggested for all neuronal growth factors mentioned above. Beyond that, animal models reveal acute exercise-induced elevations within the CNS. Potential correlations between increased levels of central neurotrophic growth factors in humans and cognitive functioning remain unclear. However, an animal study indicated a relationship between elevated concentrations in the hippocampus and improved learning and memory (6).

Exercise and Inflammation

Chronic low-grade systemic inflammation represents a well-approved risk factor for several chronic diseases, such as internistic (e.g. cancer) or neurodegenerative diseases (e.g. AD, PD, MS) (16, 66). Low-grade systemic inflammation implies an increased number of circulating pro-inflammatory mediators, as especially indicted by interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and C-reactive protein (CRP) (16).

Highly regarded, physical inactivity and sedentary behaviour favour the development and persistence of chronic low-grade systemic inflammation (20, 29). An inactive lifestyle promotes the accumulation of adipose tissue, leading to an increased production of pro-inflammatory cytokines (42). Moreover, in adipose tissue numbers of type 1 macrophages and other pro-infl ammatory immune cell subsets are elevated, while anti-infl ammatory regulatory T-cells (Tregs) are decreased (29). Infl ammation that was originally located in adipose tissue becomes systematic as pro-infl ammatory mediators enter the blood stream, thereby transferring the infl ammatory signals to other organs and tissues including the CNS, liver, muscle and intestine. Th is transfer of locally derived infl ammation in adipose tissue to systemic milieu, also described as “metafl ammation”, indicates a progressive metabolically induced infl ammation and is a substantial factor for chronic low-grade infl ammatory conditions (29). In addition, ageing is directly linked to lowgrade systemic infl ammation. Th is “infl ammaging” can partially explained by alterations in body composition during the process of ageing. However, studies have shown, that ageing also activates pro-infl ammatory signalling on the epigenetic level, a negative development which can be reduced by physical exercise (40).

A vast body of evidence suggests that exercise has various anti-infl ammatory properties (16, 66). In this context, direct and indirect anti-infl ammatory eff ects can be distinguished. Regarding the indirect eff ect, a reduction of adipose tissue in response to chronic exercise stimuli counteracts the previously described infl ammatory eff ects (66).

Concerning direct eff ects, several mechanisms have been suggested. Firstly, acute bouts of exercise induce the release of IL-6 from contracting muscle (44), which is followed by the expression of anti-infl ammatory cytokines, such as IL-10 and IL-1 receptor antagonist. Th e latter response inhibits further immune reactions (16). Secondly, chronic exercise was described to reduce the expression of Toll-like receptors (TLRs) on monocytes and macrophages (16), resulting in a decreased production of pro-infl ammatory cytokines and thereby leading to immune suppression. Finally, evidence suggests that chronic endurance exercise, as indicated by an increased cardiovascular fi tness, is associated with greater numbers of circulating anti-infl ammatory Tregs (67).

Exercise and Immune Cells in the CNS

For a long time, the brain has been considered an immune-privileged organ, protected from peripheral infl ammation with microglial cells being the only cells that contribute to immune-surveillance in the CNS. Microglia make up 10% of the cells in the CNS and represent the brain-resident macrophages that play an important role in tissue homeostasis and proper brain functioning, but also infl ammation (35). However, research in the last two decades disproved the assumption of the brain as an immune-privileged organ by demonstrating that the CNS is just partly immune-privileged (15), since

1. there are immune cells (i.e. macrophages, dendritic cells and T cells) that reside CNS borders such as choroid plexus and meninges and hold supervising function (27)

2. under acute or chronic neuroinfl ammatory states, peripheral immune cells (i.e. activated macrophages and T cells) invade into the CNS through diff erent sites and contribute to local infl ammatory processes (32).

Polarization of otherwise resting microglia to the proinfl ammatory (M1) phenotype is pivotal for the infl ammatory response observed in chronic neurodegeneration such as MS, PD and AD. Th e secretion of proinfl ammatory molecules and neurotoxins by activated microglia and infi ltrated leukocytes leads to an amplifi cation of microglial activity and further activates astrocytes, which represent the major constituent of glial cells in the brain (9). Th e emerging chronic proinfl ammatory microenvironment provokes dysregulation of brain homeostasis, BBB disruption and neurotoxicity, ultimately leading to neurological symptoms and chronic neurodegeneration.

A recent systematic review of 51 studies revealed that there is a relationship between systemic inflammation and microglial activation (22). Systemic inflammation is a common hallmark of people suffering from neurodegenerative disorders (10, 61). Since physical activity or exercise possesses potent systemic anti-inflammatory and immunoregulatory effects (see section Exercise and Inflammation), there is a clear indication of exercise to counteract microglial activity and neuroinflammation in neurodegenerative disorders. It has been shown that there might be a causal link between both an increase in circulating Tregs and Treg functionality and cardiovascular fitness in humans (67). Peripheral Tregs are able to invade the CNS during neuroinflammation to keep the immune response in check and are a hot topic in the treatment of neurodegenerative disorders (54). Interestingly, a recent mouse model provides substantial evidence of cerebral Tregs to augment neurological recovery, thereby possibly contributing to neuronal protection against neuroinflammatory diseases (24). The exercise intensity seems to play an important role as a mouse model revealed that only high-intensity swimming provokes a significant increase of Tregs in the CNS while the invasion of proinflammatory TH1 and TH17 cells is significantly reduced (68). This improved immune-homeostatic state was accompanied by attenuated clinical scores and reduced demyelination of spinal cords. However, the study design does not reveal whether it is the effect of high-intensity training before or during the induction of experimental autoimmune encephalomyelitis or even the combination of both that entails the beneficial effect.

Another study showed that voluntary exercise for six weeks attenuated the accumulation of amyloid plaques in aged rats and significantly decreased the numbers of activated astrocytes and microglia within the hippocampus and cortex, underlining exercise-induced reduction of neuroinflammation (21).

It is important to keep in mind that such delicate experimental designs can solely be performed in animals due to methodological limitations and, of course, ethical considerations. Despite careful interpretation, those results might give rise to encourage researchers to find some sophisticated ways to do basic research regarding exercise-induced amelioration of neuroinflammation in humans.

Exercise and the Blood-Brain Barrier

The invasion of peripheral immune cells into the CNS during a temporary neuroinflammatory state seems to be a crucial physiological mechanism for CNS protection, repair and maintenance (52). However, in the course of an autoimmune neuroinflammatory disease such as multiple sclerosis (MS) or other neurodegenerative disorders, the chronic proinflammatory microenvironment within the CNS promotes a continuous invasion of activated peripheral immune cells or neurotoxic substances, thereby exacerbating the local inflammatory response (10, 61). An important prerequisite for leukocyte diapedesis into brain parenchyma is an increased permeability of the blood-brain barrier (BBB). The BBB represents the capillary endothelium that separates peripheral blood from the brain parenchyma and serves as a physiological gatekeeper to protect the CNS from the entrance of blood-borne substances or cells with neurotoxic characteristics.

There is now emerging evidence of an impaired BBB integrity in the pathogenesis and disease progression of neurogenerative disorders like MS or PD (10, 17). Mechanistically, intercellular proteins tightly connect adjacent endothelial brain cells – which is why they are called tight junctions – to control paracellular transport of circulating substances. Partial dysregulation or disruption of tight junctions might be mediated by inflammatory and neuroimmune mechanisms and could promote regional hypoxia and translocation of vasculotoxic and neurotoxic molecules into the CNS, leading to neuroinflammation and, ultimately, to neurodegeneration. Souza and colleagues (53) have shown that both, endurance and strength training stabilize tight junctions at the BBB of mice suffering from experimentally induced encephalomyelitis. In contrast, only endurance training significantly reduced the permeability of the BBB and led to a more distinct reduction in clinical signs.

One major underlying mechanism of a functional loss of tight junctions may be the secretion and activation of so-called matrix metalloproteinases (MMPs) by activated brain-resident glial cells and invading proinflammatory immune cells (47). These proteolytic enzymes are able to degrade the cerebrovascular basement membrane and tight junction proteins in brain endothelial cells, which in turn increases BBB permeability. Further, a rat model revealed that MMPs degrade myelin basic protein that is responsible for adhesion of the cytosolic surfaces of multilayered compact myelin, thereby promoting demyelination and possibly driving disease progression in people with MS (36). These immunopathogenic properties make the MMPs a promising target of drugs and adjuvant therapeutic approaches to counteract neurodegeneration (4).

In the last decades, research in the field of exercise science revealed potent immuno- and neuromodulatory effects of regular exercise (see section Exercise and Growth Factors and Exercise and Inflammation). Interestingly, three weeks of high intensity interval training significantly reduced the MMP-2 concentration in persons with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) (70). Furthermore, a recent systematic review of intervention studies concludes that exercise training positively modulates BBB permeability markers in people with MS, i.e. MMPs and S100b (41). The latter is a brain-derived peptide produced mainly by astrocytes and is used in clinical research. It represents a biomarker of BBB integrity with high serum levels indicating an increased permeability. It is also discussed in the context of neurodegenerative diseases (49, 55). It was additionally shown that improved global cognitive function following a moderate intensity aerobic training regimen thrice weekly over six months was related to the reduction in circulating S100b levels (3). A currently published review proposes a theoretical framework on the crosstalk between physical exercise and BBB permeability and highlights the benefits of exercise as a prevention strategy as well as a non-pharmacological, complement treatment of neuroinflammatory and neurodegenerative disorders (34).

The increasing evidence of an exercise-induced amelioration of BBB integrity justifies regular physical exercise as a promising approach to improve clinical outcomes and to delay disease progression in people suffering from neurodegenerative disorders such as MS and PD.

Exercise and the Kynurenine Pathway

Recently, growing research interest focusses on the degradation of the essential amino acid Tryptophan (TRP) along the Kynurenine (KYN) Pathway. In contrast to the most popular TRP metabolites serotonin and melatonin, the vast majority of available TRP (over 95%) is degraded through the KYN pathway, which is accompanied by distinct neuro-immunological effects (5). A great number of neurological diseases (e.g. MS, PD, AD) is associated with dysregulations along the KYN pathway (65). Currently, several central and rate-limiting KYN pathway enzymes, such as Indoleamine 2,3 dioxgenase (IDO) or Kynurenine 3 monooxygenase (KMO), represent promising therapeutic drug targets (65).

To date, little but promising evidence suggests a modulatory impact of acute exercise bouts and chronic training on KYN pathway regulation (37). Acute endurance exercise can induce an activation of the KYN pathway as indicated by decreased levels of TRP and increased levels of KYN following exercise cessation in healthy adults (56) and persons with MS (2). Since KYN itself possess immunosuppressive properties (e.g. differentiation of Tregs, reduced cytotoxicity of T- and NK-cells) (5), repetitive short-term upregulations of peripheral KYN levels could lead to longer-term anti-inflammatory effects of exercise, as previously described (see section Exercise and Inflammation).

Furthermore, exercise-induced modulations of the KYN pathway were mostly investigated focusing on the TRP metabolite Kynurenine acid (KA). Animal and human studies indicate that both acute exercise and chronic training increases the flux of the KYN pathway yielding KA (1,31). As underlying mechanism, an PGC1-αtranscription co-activator mediated upregulation of the rate-liming enzymes Kynurenine aminotransferases (KATs) in skeletal muscle has been suggested (1). KATs are responsible for the conversion of KYN to KA. While KYN can penetrate the BBB, KA cannot. Consequently, an increased peripheral conversion of KYN to KA mediated by an exercise-induced upregulation of KATs prevents an accumulation of KYN within the CNS. Hence, an enhanced peripheral KYN clearance towards KA by exercise describes a neuroprotective mechanism which could be of major relevance for the development and/or progress of neurodegenerative diseases.

Finally, also peripheral levels of the TRP metabolite Quinolinic acid (QA) can be affected by acute exercise. Some studies in humans indicate that peripheral QA concentrations are elevated following acute endurance exercise (31, 51). QA is known to be a highly neurotoxic agent within the CNS, mainly due to its effects as N-methyl-D-aspartate receptor (NMDA) agonist (18). However, QA, just like KA, is neither able to penetrate the BBB. Thus, an acute exercise-induced enhanced peripheral KYN clearance towards QA might represent a similar neuroprotective mechanism as described for KA. Moreover, QA is a direct precursor of the substrate NAD+, which is highly relevant for oxidative energy metabolism (69). Future research is warranted to focus on a potential link between exercise-induced KYN pathway modulations and NAD+demand during and following exercise.


In conclusion, physical activity and exercise seem to be a promising additional treatment for neurodegenerative and neurological disorders, not only to alleviate disease-related symptoms but also to potentially affect the course of disease. Exercise has already shown to improve physical capacity and to reduce motoric, cognitive and affective symptoms leading to an enhanced quality of life. The described alterations in substantial biological mechanisms provoked by exercise might be underlying for the amelioration of symptoms in neurological diseases. In order to improve exercise recommendations more sophisticated approaches with combinations of clinical trials and basic research are needed, thereby filling the gap from bench to bedside.

Conflict of Interest
The authors have no conflict of interest.


  2. BANSI J, KOLIAMITRA C, BLOCH W, JOISTEN N, SCHENK A, WATSON M,KOOL J, LANGDON D, DALGAS U, KESSELRING J, ZIMMER P. Persons withsecondary progressive and relapsing remitting multiple sclerosisreveal different responses of tryptophan metabolism to acuteendurance exercise and training. J Neuroimmunol. 2018; 314: 101-105.
  3. BARHA CK, HSIUNG GYR, LIU-AMBROSE T. The Role of S100B inAerobic Training Efficacy in Older Adults with Mild VascularCognitive Impairment: Secondary Analysis of a RandomizedControlled Trial. Neuroscience. 2019; 410: 176-182.
  4. BRKIC M, BALUSU S, LIBERT C, VANDENBROUCKE RE. Friends or Foes:Matrix Metalloproteinases and Their Multifaceted Roles inNeurodegenerative Diseases. Mediators Inflamm. 2015; 2015:1-27.
  5. CERVENKA I, AGUDELO LZ, RUAS JL. Kynurenines: Tryptophan’smetabolites in exercise, inflammation, and mental health.Science. 2017; 357: eaaf9794.
  6. CETINKAYA C, SISMAN AR, KIRAY M, CAMSARI UM, GENCOGLU C,BAYKARA B, AKSU I, UYSAL N. Positive effects of aerobic exerciseon learning and memory functioning, which correlate withhippocampal IGF-1 increase in adolescent rats. Neurosci Lett.2013; 549: 177-181.
  7. CHEN H, ZHANG SM, SCHWARZSCHILD MA, HERNAN MA, ASCHERIO A. Physical activity and the risk of Parkinson disease. Neurology.2005; 64: 664-669.
  8. CLOUSTON SAP, BREWSTER P, KUH D, RICHARDS M, COOPER R, HARDY R,RUBIN MS, HOFER SM. The dynamic relationship between physicalfunction and cognition in longitudinal aging cohorts. EpidemiolRev. 2013; 35: 33-50.
  9. CUNNINGHAM C. Microglia and neurodegeneration: The roleof systemic inflammation. Glia. 2013; 61: 71-90.
  10. DENDROU CA, FUGGER L, FRIESE MA. Immunopathology of multiplesclerosis. Nat Rev Immunol. 2015; 15: 545-558.
  11. DINOFF A, HERRMANN N, SWARDFAGER W, LIU CS, SHERMAN C,CHAN S, LANCTÔT KL. The Effect of exercise training on restingconcentrations of peripheral brain-derived neurotrophicfactor (BDNF): A meta-analysis. PLoS One. 2016; 11: e0163037.
  12. FERRIS LT, WILLIAMS JS, SHEN CL. The effect of acute exercise onserum brain-derived neurotrophic factor levels and cognitivefunction. Med Sci Sports Exerc. 2007; 39: 728-734.
  13. FIRTH J, STUBBS B, VANCAMPFORT D, SCHUCH F, LAGOPOULOS J,ROSENBAUM S, WARD PB. Effect of aerobic exercise onhippocampal volume in humans: A systematic review andmeta-analysis. Neuroimage. 2018; 166: 230-238.
  14. FOX J, RIOUX B V, GOULET EDB, JOHANSSEN NM, SWIFT DL, BOUCHARD DR,LOEWEN H, SÉNÉCHAL M. Effect of an acute exercise bout onimmediate post-exercise irisin concentration in adults: A metaanalysis.Scand J Med Sci Sports. 2018; 28: 16-28.
  15. GALEA I, BECHMANN I, PERRY VH. What is immune privilege (not)?Trends Immunol. 2007; 28: 12-18.
  16. GLEESON M, BISHOP NC, STENSEL DJ, LINDLEY MR, MASTANA SS, NIMMO MA. The anti-inflammatory effects of exercise: Mechanisms andimplications for the prevention and treatment of disease. NatRev Immunol. 2011; 11: 607-615.
  17. GRAY MT, WOULFE JM. Striatal blood-brain barrier permeability inParkinson’s disease. J Cereb Blood Flow Metab. 2015; 35: 747-750.
  18. GUILLEMIN GJ. Quinolinic acid, the inescapable neurotoxin. FEBSJ. 2012; 279: 1356-1365.
  19. GUURE CB, IBRAHIM NA, ADAM MB, SAID SM. Impact of PhysicalActivity on Cognitive Decline, Dementia, and Its Subtypes:Meta-Analysis of Prospective Studies. Biomed Res Int. 2017; 2017:9016924.
  20. HANDSCHIN C, SPIEGELMAN BM. The role of exercise and PGC1alphain inflammation and chronic disease. Nature. 2008; 454: 463-469.
  21. HE X, LIU D, ZHANG Q, LIANG FY, DAI GY, ZENG JS, PEI Z, XU GQ, LAN Y. Voluntary Exercise Promotes Glymphatic Clearance of AmyloidBeta and Reduces the Activation of Astrocytes and Microgliain Aged Mice. Front Mol Neurosci. 2017; 10: 144.
  22. HOOGLAND ICM, HOUBOLT C, VAN WESTERLOO DJ, VAN GOOL WA, VANDE BEEK D. Systemic inflammation and microglial activation:Systematic review of animal experiments. J Neuroinflammation.2015; 12: 114.
  23. HUNT TK, ASLAM RS, BECKERT S, WAGNER S, GHANI QP, HUSSAIN MZ,ROY S, SEN CK. Aerobically Derived Lactate StimulatesRevascularization and Tissue Repair via Redox Mechanisms.Antioxid Redox Signal. 2007; 9: 1115-1124.
  24. ITO M, KOMAI K, MISE-OMATA S, IIZUKA-KOGA M, NOGUCHI Y, KONDO T,SAKAI R, MATSUO K, NAKAYAMA T, YOSHIE O, NAKATSUKASA H, CHIKUMA S,SHICHITA T, YOSHIMURA A. Brain regulatory T cells suppressastrogliosis and potentiate neurological recovery. Nature. 2019;565: 246-250.
  25. JEON YK, HA CH. The effect of exercise intensity on brain derivedneurotrophic factor and memory in adolescents. Environ HealthPrev Med. 2017; 22: 27.
  26. JIMÉNEZ-MALDONADO A, RENTERÍA I, GARCÍA-SUÁREZ PC, MONCADAJIMÉNEZJ, FREIRE-ROYES LF. The impact of high-intensity intervaltraining on brain derived neurotrophic factor in brain: Amini-review. Front Neurosci. 2018; 12: 839.
  27. KIPNIS J. Multifaceted interactions between adaptive immunityand the central nervous system. Science. 2016; 353: 766-771.
  28. KJØLHEDE T, SIEMONSEN S, WENZEL D, STELLMANN J-P, RINGGAARD S,GINNERUP PEDERSEN B, STENAGER E, PETERSEN T, VISSING K, HEESEN C,DALGAS U. Can resistance training impact MRI outcomes inrelapsing-remitting multiple sclerosis? Mult Scler J. 2018; 24:1356-1365.
  29. KRÜGER K. Inflammation during Obesity – PathophysiologicalConcepts and Effects of Physical Activity. Dtsch Z Sportmed.2017; 68: 163-169.
  30. LABANDEIRA-GARCIA JL, COSTA-BESADA MA, LABANDEIRA CM, VILLARCHEDAB, RODRÍGUEZ-PEREZ AI. Insulin-like growth factor-1and neuroinflammation. Front Aging Neurosci. 2017; 9: 365.
  32. LOUVEAU A, HERZ J, ALME MN, SALVADOR AF, DONG MQ, VIAR KE, HEROD SG,KNOPP J, SETLIFF JC, LUPI AL, DA MESQUITA S, FROST EL, GAULTIER A,HARRIS TH, CAO R, HU S, LUKENS JR, SMIRNOV I, OVERALL CC, OLIVER G,KIPNIS J. CNS lymphatic drainage and neuroinflammation areregulated by meningeal lymphatic vasculature. Nat Neurosci.2018; 21: 1380-1391.
  33. MAK IW, EVANIEW N, GHERT M. Lost in translation: animal models andclinical trials in cancer treatment. Am J Transl Res. 2014; 6: 114-118.
  34. MAŁKIEWICZ MA, SZARMACH A, SABISZ A, CUBAŁA WJ, SZUROWSKA E,WINKLEWSKI PJ. Blood-brain barrier permeability and physicalexercise. J Neuroinflammation. 2019; 16: 15.
  36. MATYSZAK MK, PERRY VH. Delayed-type hypersensitivity lesionsin the central nervous system are prevented by inhibitors ofmatrix metalloproteinases. J Neuroimmunol. 1996; 69: 141-149.
  37. METCALFE AJ, KOLIAMITRA C, JAVELLE F, BLOCH W, ZIMMER P. Acute andchronic effects of exercise on the kynurenine pathway in humans– A brief review and future perspectives. Physiol Behav. 2018;194: 583-587.
  38. MINN Y-K, CHOI SH, SUH YJ, JEONG JH, KIM E-J, KIM JH, PARK KW, PARK MH,YOUN YC, YOON B, CHOI S-J, OH YK, YOON SJ. Effect of Physical Activityon the Progression of Alzheimer’s Disease: The Clinical ResearchCenter for Dementia of South Korea Study. J Alzheimers Dis.2018; 66: 249-261.
  40. NAKAJIMA K, TAKEOKA M, MORI M, HASHIMOTO S, SAKURAI A, NOSE H,HIGUCHI K, ITANO N, SHIOHARA M, OH T, TANIGUCHI S. Exercise effectson methylation of ASC gene. Int J Sports Med. 2010; 31: 671-675.
  41. NEGARESH R, MOTL RW, ZIMMER P, MOKHTARZADE M, BAKER JS. Effectsof exercise training on multiple sclerosis biomarkers of centralnervous system and disease status: a systematic review ofintervention studies. Eur J Neurol. 2019; 26: 711-721.
  42. OUCHI N, PARKER JL, LUGUS JJ, WALSH K. Adipokines in inflammationand metabolic disease. Nat Rev Immunol. 2011; 11: 85-97.
  43. PARK H, POO MM. Neurotrophin regulation of neural circuitdevelopment and function. Nat Rev Neurosci. 2013; 14: 7-23.
  44. PEDERSEN BK, FEBBRAIO MA. Muscle as an Endocrine Organ: Focuson Muscle-Derived Interleukin-6. Physiol Rev. 2008; 88: 1379-1406.
  45. QIU S, CAI X, SUN Z, SCHUMANN U, ZÜGEL M, STEINACKER JM. ChronicExercise Training and Circulating Irisin in Adults: A Meta-Analysis. Sports Med. 2015; 45: 1577-1588.
  46. RASMUSSEN P, BRASSARD P, ADSER H, PEDERSEN M V, LEICK L,HART E, SECHER NH, PEDERSEN BK, PILEGAARD H. Evidence for arelease of brain-derived neurotrophic factor from the brainduring exercise. Exp Physiol. 2009; 94: 1062-1069.
  47. REMPE RG, HARTZ AMS, BAUER B. Matrix metalloproteinasesin the brain and blood-brain barrier: Versatile breakersand makers. J Cereb Blood Flow Metab. 2016; 36: 1481-1507.
  48. ROJAS VEGA S, ABEL T, LINDSCHULTEN R, HOLLMANN W, BLOCH W,STRÜDER HK. Impact of exercise on neuroplasticity-relatedproteins in spinal cord injured humans. Neuroscience. 2008; 153:1064-1070.
  49. ROTHERMUNDT M, PETERS M, PREHN JHM, AROLT V. S100B in braindamage and neurodegeneration. Microsc Res Tech. 2003; 60: 614-632.
  50. RUIZ DE ALMODOVAR C, LAMBRECHTS D, MAZZONE M, CARMELIET P. Roleand therapeutic potential of VEGF in the nervous system. PhysiolRev. 2009; 89: 607-648.
  51. SCHLITTLER M, GOINY M, AGUDELO LZ, VENCKUNAS T, BRAZAITIS M,SKURVYDAS A, KAMANDULIS S, RUAS JL, ERHARDT S, WESTERBLAD H,ANDERSSON DC. Endurance exercise increases skeletal musclekynurenine aminotransferases and plasma kynurenic acid inhumans. Am J Physiol Physiol. 2016; 310: C836-C840.
  52. SCHWARTZ M, BARUCH K. The resolution of neuroinflammationin neurodegeneration: Leukocyte recruitment via the choroidplexus. EMBO J. 2014; 33: 7-22.
  53. SOUZA PS, GONÇALVES ED, PEDROSO GS, FARIAS HR, JUNQUEIRA SC,MARCON R, TUON T, COLA M, SILVEIRA PCL, SANTOS AR, CALIXTO JB,SOUZA CT, DE PINHO RA, DUTRA RC. Physical Exercise AttenuatesExperimental Autoimmune Encephalomyelitis by InhibitingPeripheral Immune Response and Blood-Brain BarrierDisruption. Mol Neurobiol. 2017; 54: 4723-4737.
  54. SPENCE A, KLEMENTOWICZ JE, BLUESTONE JA, TANG Q. Targeting Tregsignaling for the treatment of autoimmune diseases. Curr OpinImmunol. 2015; 37: 11-20.
  55. STEINER J, BOGERTS B, SCHROETER ML, BERNSTEIN HG. S100B proteinin neurodegenerative disorders. Clin Chem Lab Med. 2011; 49:409-424.
  56. STRASSER B, GEIGER D, SCHAUER M, GATTERER H, BURTSCHER M,FUCHS D. Effects of exhaustive aerobic exercise on tryptophankynureninemetabolism in trained athletes. PLoS One. 2016; 11:e0153617.
  57. STRÖHLE A, STOY M, GRAETZ B, SCHEEL M, WITTMANN A, GALLINAT J,LANG UE, DIMEO F, HELLWEG R. Acute exercise amelioratesreduced brain-derived neurotrophic factor in patients withpanic disorder. Psychoneuroendocrinology. 2010; 35: 364-368.
  58. SUN M, LANCTOT K, HERRMANN N, GALLAGHER D. Exercise forCognitive Symptoms in Depression: A Systematic Review ofInterventional Studies. Can J Psychiatry. 2018; 63: 115-128.
  59. SZUHANY KL, BUGATTI M, OTTO MW. A meta-analytic reviewof the effects of exercise on brain-derived neurotrophicfactor. J Psychiatr Res. 2015; 60: 56-64.
  60. TANG K, XIA FC, WAGNER PD, BREEN EC. Exercise-induced VEGFtranscriptional activation in brain, lung and skeletal muscle.Respir Physiol Neurobiol. 2010; 170: 16-22.
  61. TANSEY MG, ROMERO-RAMOS M. Immune system responses inParkinson’s disease: Early and dynamic. Eur J Neurosci. 2019; 49:364-383.
  62. THIER P. Die funktionelle Architektur des präfrontalen Kortex BT- Kognitive Neurowissenschaften. In: Karnath H-O, Thier P (eds.).Berlin, Heidelberg: Springer Berlin Heidelberg, 2012: 575–583.
  63. TONOLI C, HEYMAN E, BUYSE L, ROELANDS B, PIACENTINI MF, BAILEY S,PATTYN N, BERTHOIN S, MEEUSEN R. Neurotrophins and cognitivefunctions in T1D compared with healthy controls: effects of ahigh-intensity exercise. Appl Physiol Nutr Metab. 2015; 40: 20-27.
  64. TSAI C-L, WANG C-H, PAN C-Y, CHEN F-C, HUANG T-H, CHOU F-Y. Executive function and endocrinological responses to acuteresistance exercise. Front Behav Neurosci. 2014; 8: 1-12.
  65. VÉCSEI L, SZALÁRDY L, FÜLÖP F, TOLDI J. Kynurenines in the CNS:Recent advances and new questions. Nat Rev Drug Discov. 2013;12: 64-82.
  66. WALSH NP, GLEESON M, SHEPHARD RJ, JEFFREY MG, WOODS A, BISHOP NC,FLESHNER M, GREEN C, PEDERSEN K, HOFFMAN-GOETZ L, ROGERS CJ,NORTHOFF H, ABBASI A, SIMON P. Position Statement. Part one:Immune function and exercise. Exerc Immunol Rev. 2011; 17:6-63.
  67. WEINHOLD M, SHIMABUKURO-VORNHAGEN A, FRANKE A, THEURICH S,WAHL P, HALLEK M, SCHMIDT A, SCHINKÖTHE T, MESTER J, VON BERGWELTBAILDONM, BLOCH W. Physical exercise modulates the homeostasisof human regulatory T cells. J Allergy Clin Immunol. 2016; 137:1607-1610.e8.
  68. XIE Y, LI Z, WANG Y, XUE X, MA W, ZHANG Y, WANG J. Effects ofmoderate- versus high- intensity swimming training oninflammatory and CD4 + T cell subset profiles in experimentalautoimmune encephalomyelitis mice. J Neuroimmunol. 2019;328: 60-67.
  69. YANG Y, SAUVE AA. NAD(+) metabolism: Bioenergetics, signalingand manipulation for therapy. Biochim Biophys Acta. 2016; 1864:1787-1800.
  70. ZIMMER P, BLOCH W, SCHENK A, OBERSTE M, RIEDEL S, KOOL J, LANGDON D,DALGAS U, KESSELRING J, BANSI J. High-intensity intervalexercise improves cognitive performance and reduces matrixmetalloproteinases-2 serum levels in persons with multiplesclerosis: A randomized controlled trial. Mult Scler J. 2018; 24:1635-1644.
  71. ZIMMER P, OBERSTE M, BLOCH W. Einfluss von Sport auf das zentraleNervensystem – Molekulare und zelluläre Wirkmechanismen.Dtsch Z Sportmed. 2015; 66: 42-49.
Dr. Dr. Philipp Zimmer
German Sport University Cologne
Department for Molecular and Cellular
Sports Medicine, Institute for Cardiovascular
Research and Sports Medicine
Am Sportpark Müngersdorf 6, 50933 Cologne